Therapist Joshua Bennett-Johnson gives a critical breakdown of xylazine’s rise in the drug supply, its deadly interaction with fentanyl, and why traditional overdose response is no longer enough. Essential reading for clinicians and communities.

Harm reduction meets people where they are - without requiring abstinence as the starting point. Dr. Andrew Tatarsky's article explains how that shift expands treatment access and improves outcomes.

John Makohen, CASAC Advanced, RCP, tells a powerful story about stigma and traditional recovery systems. What happens when the system meant to help you rejects you?